Dare Bioscience, Inc. Convertible Notes Payable, Current
Dare Bioscience, Inc. (DARE) had Convertible Notes Payable, Current of $852.50 thousand as of 2017-06-30, per its 8-K/A filed 2017-10-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2018-03-28
- 2017-06-30: Convertible Notes Payable, Current $852.50K.
- 2016-12-31: Convertible Notes Payable, Current $697.50K.
- 2015-12-31: Convertible Notes Payable, Current $500.00K.
- 2014-03-31: Convertible Notes Payable, Current $17.32M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2017-06-30 | $852.50K 8-K/A · filed 2017-10-02 |
| 2016-12-31 | $697.50K 10-K · filed 2018-03-28 |
| 2015-12-31 | $500.00K 8-K/A · filed 2017-10-02 |
| 2014-03-31 | $17.32M 10-Q · filed 2014-05-27 |
| 2013-12-31 | $8.82M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |